Sunday, 27 April 2014
INDIAN BENCHMARK open flat with a
negative bias tracking weakness in its Asian peers. Jubilant Life
Sciences receives ANDA approval for Spironolactone Tablets.
FURTHER, IDFC lost 2.72%
after consolidated net profit declined 50.93% to Rs 257.94 crore on 0.05%
growth in total income to Rs 2219.57 crore in Q4 March 2014 over Q4 March
2013.Siemens gained 2.36% after net profit jumped 194.7% to Rs 88.27 crore on
8.6% fall in net sales to Rs 2657.74 crore in Q2 March 2014 over Q2 March 2013.
Trend in FII flows: The FIIs were net buyers of Rs.295cr
in the cash segment on Friday while the domestic institutional investors (DIIs)
were net sellers of Rs. 417cr, as per the provisional figures
released by the NSE.
